Exane BNP Paribas Downgrades GlaxoSmithKline (GSK) to Underperform

September 13, 2016 12:56 PM EDT
Get Alerts GSK Hot Sheet
Price: $40.42 +0.20%

Rating Summary:
    6 Buy, 10 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 25 | Down: 28 | New: 8
Trade GSK Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Exane BNP Paribas downgraded GlaxoSmithKline (NYSE: GSK) from Neutral to Underperform.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $43.30 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment